Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer

NCT06833866 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Advanced or Metastatic CRC

Interventions

DRUG: Hydroxytyrosol

Sponsor

The Methodist Hospital Research Institute